Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
